CervoMed

CRVONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$38.251 M

$2.53 +4.98%

Close of 22 Sept 2026

Revenue

$4.01M

#3324 by revenue

Earnings

-$27.0M

Loss-making

Shares outstanding

15,119,096

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#366Seres TherapeuticsMCRB$40.4M
#367NanoviricidesNNVC$39.1M
#368CervoMedCRVO$38.3M
#369Mira PharmaceuticalsMIRA$38.1M
#370Actinium PharmaceuticalsATNM$36.8M

What if CervoMed were worth as much as…

Open the what-if tool →

Gold $30.2T

$1,999,721

Per share 790,403× higher

Bitcoin $1.74T

$115,195.71

Per share 45,532× higher

Nvidia $5.52T

$364,821.22

Per share 144,198× higher

Or at a round number

$50.0M $100.0M $200.0M $500.0M

Where these numbers come from

Share counts and financials for CervoMed are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.